Key Project Highlights
✅ Massive ₹5,000 crore investment in new API & formulations plant
✅ Location: Rambilli village, Anakapalli district (100+ acres allotted)
✅ Focus areas: Oncology, ARV, and specialty generics manufacturing
✅ Capacity expansion: To become one of India’s largest pharma production hubs
Strategic Significance for Andhra Pradesh
Why Rambilli?
✔ Proximity to Visakhapatnam Port – Enables smooth exports
✔ Pharma ecosystem – Close to existing pharma clusters
✔ Government support – AP’s active industry-friendly policies
Employment & Economic Impact
- Direct employment: 5,000+ jobs
- Indirect opportunities: 15,000+ in ancillary units
- Boost to local economy: Expected ₹15,000 crore economic impact over 5 years
Manufacturing Capabilities
🔬 Advanced API production
💊 High-potency oncology formulations
🌍 Global export focus (US, EU, Japan markets)
♻ Green manufacturing with sustainability focus
Leadership Statements
Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs:
“This expansion aligns with our vision to become a global leader in active pharmaceutical ingredients. Andhra Pradesh’s infrastructure and policy support make it an ideal location.”
AP Industries Minister Gudivada Amarnath:
“This mega investment puts Andhra Pradesh firmly on the global pharma map. We’re committed to providing all necessary support for timely project completion.”
Industry Context
- India’s API market to reach $57.8 billion by 2025
- Andhra emerging as alternative to Hyderabad pharma hub
- Recent investments: Hetero, Aurobindo expanding in AP
Project Timeline
📅 Land allotment: August 2024
🏗 Construction begins: Q1 2025
🏭 Phase 1 operational: Mid-2027
Broader Impact
- Strengthens India’s position as “Pharmacy of the World”
- Reduces import dependence for critical APIs
- Attracts more investments to Andhra’s pharma sector
